Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides

ABSTRACT: Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides

PROVIDER: PRJNA983340 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides [II]

Project description:NanoString based gene expression data from skin biopsies from nine mycosis fungoides patients before and after phototherapy as well as four healthy donor skin as a comparator

2023-06-14 | GSE234854 | GEO

Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides [I]

Project description:NanoString based gene expression data from skin biopsies from nine mycosis fungoides patients before and after phototherapy as well as four healthy donor skin as a comparator

2023-06-14 | GSE234852 | GEO

Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides [I]

Project description:Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides [I]

| PRJNA983343 | ENA

Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides [II]

Project description:Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides [II]

| PRJNA983348 | ENA

Mycosis fungoides

Project description:Mycosis fungoides

| PRJNA430861 | ENA

Mycosis fungoides

Project description:Mycosis fungoides (MF) is the most common and best studied of cutaneous T-cell lymphoma (CTCL). Three clinical cutaneous stages have been described (patch, plaque and tumor) as the disease progress developing also the disease lymph node, peripheral blood or systemic involvement in late stages. Clinical and pathologic diagnosis of early MF stages (patch and plaque) is difficult as its morphologic similarity to inflammatory dermatoses and low proportion of tumoral cells.

2018-06-21 | GSE109421 | GEO

RNAseq of the skin of patients with Mycosis fungoides

Project description:We performed transcriptome analysis and multimodal data integration of the transcriptome and the microbiome of the skin of Mycosis fungoides Patients.

2023-12-01 | GSE221148 | GEO

ALTERATIONS IN THE SKIN MICROBIOTA ARE ASSOCIATED WITH SYMPTOM SEVERITY IN MYCOSIS FUNGOIDES

Project description:We identified skin microbiota signatures related to different symptoms, i.e. pain, pruritus, in patients with Mycosis Fungoides.

2022-04-11 | GSE186083 | GEO

CD8+ T lymphocytes in hypopigmented mycosis fungoides: malignant cells or reactive clone?

Project description:We used targeted single cell RNA sequencing using a gene set composed of the BD Rhapsody Human Immune Response Panel, TCR panel, and a custom panel of 61 malignancy-associated genes and T/B cell receptor sequencing to characterize single cell populations in hypopigmented mycosis fungoides (HMF). Using a reference mapping model built on publically deposited classic mycosis fungoides single cell RNA sequencing datasets, we identified a predicted malignant cell population independent from the clonal T cell population in HMF.

2023-10-17 | GSE212146 | GEO

The Skin Microbiome of Mycosis fungoides

Project description:The Skin Microbiome of Mycosis fungoides

| PRJNA913116 | ENA